The fifteenth mainline game in the Final Fantasy series, Final Fantasy XV has arguably one of the most troubled development [ ...
Truecaller’s latest valuation reset has seen its fair value estimate cut from roughly SEK 50.83 to SEK 39.17 per share, as analysts dial back their medium term growth optimism while still ...
If you are wondering whether Mineralys Therapeutics is still worth buying after its big run, you are not alone. This is exactly what we are going to unpack. The stock has pulled back about 12.1% over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback